Tejada Julio G, Velazquez Maite, Hernandez Felipe, Albarran Agustín, Gomez Ivan, Rodriguez Sergio, Andreu Javier, Tascon Juan
Servicio de Cardiología, Hospital doce de Octubre, Madrid, Spain.
Int J Cardiol. 2009 May 15;134(2):201-6. doi: 10.1016/j.ijcard.2008.01.042. Epub 2008 May 27.
An increasing number of patients undergoing percutaneous interventions (PI) have experienced previous coronary artery bypass graft surgery (CABG). However, the impact of PI on outcomes in such patients is currently unclear. We evaluated the immediate and 1-year clinical outcomes of post-CABG patients who underwent PI in a tertiary center.
From January-2005 to September-2006, 91 consecutive post-CABG patients underwent 197 stent implantations (84% drug-eluting stents) for 154 lesions. 58% were treated in the native coronary arteries, 34% in the grafts and 8% in both type of vessels. Major adverse cardiac events (MACE) were recorded in-hospital and at 1-year follow-up.
Procedural success rate was 95.6%. In-hospital MACE rate was 3.3%. At 1 year, the incidence of MACE was 18.6%: death occurred in 5.4% of the patients, myocardial infarction in 2.2%, and 10.9% of the patients underwent repeat revascularization (target lesion revascularization was required in 5.4%). Multivariate analysis revealed left ventricular ejection fraction <50% (OR 4.6, 95% CI 1.8 to 7.5, p=0.01) and multivessel intervention (OR 2.7, 95% CI 1.2 to 4.5, p=0.03) to be independent predictors of MACE at 1 year.
Immediate results showed the safety and efficacy of percutaneous revascularization in post-CABG patients. The relatively low risk need for target lesion revascularization obtained is encouraging. Independent predictors of MACE at 1 year were left ventricular disfunction and multivessel intervention.
越来越多接受经皮介入治疗(PI)的患者曾接受过冠状动脉旁路移植术(CABG)。然而,目前PI对此类患者预后的影响尚不清楚。我们评估了在一家三级中心接受PI的CABG术后患者的即刻及1年临床预后。
2005年1月至2006年9月,91例连续的CABG术后患者因154处病变接受了197次支架植入(84%为药物洗脱支架)。58%在自身冠状动脉进行治疗,34%在移植血管,8%在两种血管。记录住院期间及1年随访时的主要不良心脏事件(MACE)。
手术成功率为95.6%。住院期间MACE发生率为3.3%。1年时,MACE发生率为18.6%:5.4%的患者死亡,2.2%发生心肌梗死,10.9%的患者接受了再次血运重建(5.4%需要靶病变血运重建)。多因素分析显示左心室射血分数<50%(OR 4.6,95%CI 1.8至7.5,p=0.01)和多支血管介入(OR 2.7,95%CI 1.2至4.5,p=0.03)是1年时MACE的独立预测因素。
即刻结果显示了CABG术后患者经皮血运重建的安全性和有效性。获得的相对较低的靶病变血运重建风险令人鼓舞。1年时MACE的独立预测因素是左心室功能障碍和多支血管介入。